Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.48 |
| ▸ | KIF11 | P52732 | 5/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | MDH1 | P40925 | 1/20 | 0.39 |
| ▸ | MDH2 | P40926 | 1/20 | 0.39 |
| ▸ | DHODH | Q02127 | 1/20 | 0.37 |
| ▸ | XDH | P47989 | 1/20 | 0.36 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.36 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.36 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20951293 | 0.94 | SHBG (0.53) | SHBGKIF11CYP3A4SMN1; SMN2MDH1 | |
| SCHEMBL411772 | 0.89 | SHBG (0.59) | SHBGCYP3A4SMN1; SMN2MDH1MDH2 | |
| SCHEMBL13321302 | 0.84 | KIF11 (0.57) | KIF11SMN1; SMN2DHODHXDHSLC22A12 | |
| SCHEMBL2957181 | 0.84 | KIF11 (0.57) | KIF11SMN1; SMN2DHODHXDHSLC22A12 | |
| SCHEMBL10515698 | 0.82 | SHBG (0.67) | SHBGKIF11CYP3A4SMN1; SMN2MDH1 | |
| SCHEMBL8962181 | 0.81 | SHBG (0.52) | SHBGCYP3A4SMN1; SMN2MDH1MDH2 | |
| SCHEMBL465314 | 0.81 | SHBG (0.47) | SHBGCYP3A4SMN1; SMN2MDH1MDH2 | |
| SCHEMBL49741 | 0.78 | TSHR (0.52) | KIF11SMN1; SMN2DHODHABCG2 | |
| SCHEMBL2392625 | 0.78 | TSHR (0.52) | KIF11SMN1; SMN2DHODHABCG2 | |
| SCHEMBL24520685 | 0.77 | SHBG (0.47) | SHBGCYP3A4SMN1; SMN2MDH1MDH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11239426-B2 | Electroactive compounds | LG CHEM, LTD. | 2022-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11239426-B2 | Electroactive compounds | KCNN2, HCN2, KCNN3 | SHBG 471/4885KIF11 3639/4885CYP3A4 310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.